Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital

被引：13
作者：
Mallaval, FO
Carricajo, A
Delavenna, F
Recule, C
Fonsale, N
Manquat, G
Raffenot, D
Rogeaux, O
Aubert, G
Tous, J
机构：
[1] Chambery Teaching Hosp, Microbiol Lab, Chambery, France
[2] St Etienne Teaching Hosp, Bacteriol Lab, St Etienne, France
[3] Grenoble Teaching Hosp, Bacteriol Lab, Grenoble, France
[4] Inter Hosp Hyg Unit, Savoie, France
[5] Chambery Hosp, Dept Infect Dis, Chambery, France
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 05期
关键词：
glycopeptide resistance; h-GISA; MRSA; outbreak; Staphylococcus aureus;
D O I：
10.1111/j.1469-0691.2004.00878.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Staphylococcus aureus isolates were screened for reduced susceptibility to glycopeptides with an initial glycopeptide agar screening test, followed by confirmation of the strains thus identified by two Etest strip techniques and population analysis. This procedure detected 48 methicillin-resistant S. aureus (MRSA) isolates with reduced susceptibility to glycopeptides from 24 patients among 883 MRSA isolates tested. The dissemination of a single clone was confirmed by pulsed-field gel electrophoresis.
引用
收藏
页码：459 / 461
页数：3
相关论文
共 14 条
  • [1] Implication of a healthcare worker with chronic skin disease in the transmission of an epidemic strain of methicillin-resistant Staphylococcus aureus in a pediatric intensive care unit
    Berthelot, P
    Grattard, F
    Fascia, P
    Fichtner, C
    Moulin, M
    Lavocat, MP
    Teyssier, G
    Lucht, F
    Pozzetto, B
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (04) : 299 - 300
  • [2] In vitro activity of β-lactams against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus
    Carricajo, A
    Fonsale, N
    Vautrin, AC
    Aubert, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 856 - 858
  • [3] Search for Staphylococcus aureus stems with decreased sensitivity with glycopeptides in a teaching hospital (June 1999 February 2000)
    Carricajo, A
    Mallaval, F
    Fonsale, N
    Vautrin, AC
    Aubert, G
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (11): : 683 - 684
  • [4] Centers for Disease Control and Prevention (CDC), 1997, MMWR MORB MORTAL WKL, V46, P765
  • [5] Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
    Chesneau, O
    Morvan, A
    El Solh, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 887 - 890
  • [6] Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542
  • [7] Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital
    Guerin, F
    Buu-Hoï, A
    Mainardi, JL
    Kac, G
    Colardelle, N
    Vaupré, S
    Gutmann, L
    Podglajen, I
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) : 2985 - 2988
  • [8] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    Hiramatsu, K
    Aritaka, N
    Hanaki, H
    Kawasaki, S
    Hosoda, Y
    Hori, S
    Fukuchi, Y
    Kobayashi, I
    [J]. LANCET, 1997, 350 (9092) : 1670 - 1673
  • [9] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136
  • [10] Heterogeneous resistance to vancomycin in Staphylococcus aureus
    Howe, RA
    Wootton, M
    Walsh, TR
    Bennett, PM
    MacGowan, AP
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 130 - 131
12